HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of International Heart Congress

June 05-07,2025 | Hybrid Event

June 05 -07, 2025 | Rome, Italy
Heart Congress 2025

Tumor-like calcification in patients undergoing hemodialysis

Omaima Taie, Speaker at Heart Conferences
Mohammed V University, Morocco
Title : Tumor-like calcification in patients undergoing hemodialysis

Abstract:

Tumor-like calcinosis is a condition where calcium phosphate crystals accumulate in the tissues around joints, forming large, calcified masses. Although the exact mechanisms are not fully understood, it is believed that an elevated calcium-phosphate product and severe hyperparathyroidism play key roles in its development. While surgery is commonly suggested for treatment, there remains ongoing debate regarding the best approach.

We describe a 63-year-old diabetic patient on long-term hemodialysis who presented with increasing pain in the left hip over the course of six months, along with limited mobility. A CT scan revealed a calcified mass in the posterior thigh, which was likely causing the sharp, electric-shock-like pain, as well as compression of the superficial femoral artery, leading to critical limb ischemia. Laboratory tests showed elevated calcium-phosphate levels and hyperparathyroidism, which supported the diagnosis of tumor-like calcinosis.

Due to the mass's close proximity to vascular and nerve structures, surgical removal was deemed unfeasible. The patient was instead managed with a conservative approach, including angioplasty to improve blood flow and alleviate symptoms. The rarity of this condition in hemodialysis patients, coupled with the calcified masses, made both the diagnosis and treatment particularly challenging.

This case highlights the diagnostic and treatment challenges of tumor-like calcinosis in chronic hemodialysis patients. Despite conservative management, the patient experienced persistent pain and functional impairment. Endovascular intervention, including double dilation with stenting, temporarily restored blood flow and relieved symptoms. However, this approach is not curative and carries a risk of rethrombosis. The complexity of managing calcinosis-related vascular complications in hemodialysis patients calls for further investigation into optimal treatment strategies for such rare cases.

Biography:

Dr. Omaima Taie studied Medicine at the Faculty of Medicine and Pharmacy, Rabat, Morocco, and graduated in 2023. She then joined the research team at Mohammed V Military Hospital, focusing on vascular and cardiac surgery. Dr. Taie has authored two publications, including a study on PCT in chronic hemodialysis patients and another on carotid body tumor management. She has completed an EMT diploma and has a keen interest in advancing healthcare through research and innovation.

Watsapp